Nanotherapeutics in Kidney Disease: Innovations, Challenges, and Future Directions.

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Nephrology

Background:

• Kidney diseases affect over 800 million people globally, requiring advanced treatments beyond symptom management.
• Current therapies for kidney diseases often lack targeted delivery, leading to suboptimal outcomes.
• Nanotechnology presents a promising avenue for developing innovative kidney disease treatments.

Purpose of the Study:

• To review the current state of nanotechnology-based therapies for kidney diseases.
• To identify the potential and challenges of nanoparticle drug delivery systems in nephrology.
• To highlight the need for refined targeting strategies and improved synthesis techniques.

Main Methods:

• Review of in vivo research on nanoparticle-mediated therapies for kidney diseases.
• Analysis of advancements in nanoparticle drug delivery for targeted renal therapy.
• Evaluation of cellular changes in kidney diseases to identify optimal therapeutic targets.

Main Results:

• Nanoparticle-based drug delivery shows potential for targeted and controlled therapeutic delivery to kidneys.
• Tailored nanomedicines can improve localization, tolerability, and efficacy by enhancing renal membrane binding.
• Challenges include inconsistent nanoparticle synthesis and difficulties in achieving kidney-specific targeting.

Conclusions:

• Nanotechnology holds transformative potential for improving kidney disease treatment outcomes.
• Overcoming challenges in synthesis and targeting is crucial for the clinical application of nanotherapeutics.
• Further development of advanced synthesis techniques and animal models is essential for advancing nanomedicine in nephrology.